Digital Health In Brief
This article was originally published in The Gray Sheet
Executive Summary
Health industry coalitions send dueling letters on whether FDA should wait or move ahead health IT policies including its mobile medical apps guidance, and more digital health in brief.
You may also be interested in...
Pending Mobile Medical Apps Guidance Provokes Heated Controversy
An impassioned debate brewing about FDA’s planned timing for finalizing mobile medical apps guidance bubbled to the surface at a recent meeting of the HHS workgroup tasked with recommending a health IT regulatory framework. Despite pressure to delay the guidance, FDA says it is still pushing ahead.
Workgroup Unveils Preliminary Health IT Regulation Proposals
An HHS-sponsored workgroup issued its initial recommendations for a health IT regulatory framework, featuring risk-based oversight, adverse event reporting and better agency coordination.
Draft Bill Aims To Clarify FDA Regulation Of Mobile Medical Apps
Draft legislation obtained by “The Gray Sheet” that seeks to restrain FDA’s oversight of mobile apps is being circulated for stakeholder comment by Rep. Marsha Blackburn, R-Tenn., and colleagues.